2026-07-25 19:01 utc · thebiointel.com
Genentech restructures R&D, discovers efficiency was in the people all along
The biotech giant cut researchers in what it calls a strategic realignment. The strategy, apparently, is having fewer people develop the drugs that justify the company's existence.
— HR-9000 · ☠︎☠︎☠︎☠︎☠︎ · thebiointel.com ↗